AXACS
CS logo
Fair Value
€48.51
Share price16 Jul
€44.767.7% undervalued intrinsic discount
Loading
1Y6.07%
7D0.58%

CS: Rising Profit Margins And Multiples Will Drive Global Expansion

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
07 Nov 24
Updated
16 Jul 26
Views
445
Not Invested

Last Update 16 Jul 26

Fair value Increased 2.11%

CS: Updated Fair Value And P/E Assumptions Will Shape Balanced Re Rating

AXA's analyst price target has been nudged higher to €50, with analysts pointing to slightly adjusted fair value estimates, updated revenue growth and margin assumptions, and modestly refined future P/E expectations as key factors supporting the change.

Analyst Commentary

Recent research commentary on AXA points to a mixed but generally constructive view, with several price target increases and one reduction reflecting different opinions on valuation, growth assumptions, and execution risk.

Bullish Takeaways

  • Several bullish analysts have raised their price targets, with figures cited at €50 and €77.10, suggesting confidence in AXA's potential relative to current market pricing.
  • Higher fair value estimates from bullish analysts indicate that updated assumptions on revenue growth, margins, and future P/E levels are seen as supportive for AXA over the medium term.
  • AXA has attracted a Buy rating and an Overweight rating, which signals that some analysts view the stock as attractive within its sector on both valuation and execution prospects.
  • The initiation of coverage with a bullish view suggests that new coverage providers see a clear investment case in AXA's business model and financial profile.

Bearish Takeaways

  • The presence of at least one price target reduction by €1 shows that not all analysts are aligned, with some expressing caution on AXA's upside relative to previous expectations.
  • Target moves are not uniformly upward, which points to differing views on how AXA can deliver on growth and profitability assumptions embedded in current valuations.
  • Investors should note that while some large banks such as JPMorgan have moved targets higher, the variation in price targets, including the lower adjustment, reflects ongoing debate about execution risks.
  • The spread between the highest cited target of €77.10 and the more moderate €50 levels highlights that analyst conviction on AXA's long term valuation range is not fully aligned.

What’s in the News for AXA

  • No recent company specific news items were provided, so investors currently have no additional event driven updates to factor into their AXA view from the supplied sources.
  • The absence of primary news stories means there are no new disclosed developments on AXA's operations, capital actions, or regulatory events in the data given.
  • With no periodical or key development entries available, recent analyst commentary and price target changes remain the main reference points for AXA in the supplied information.

Valuation Changes for AXA

  • Fair Value increased slightly to €48.51 from €47.51, reflecting a modest uplift in the estimated intrinsic value per share.
  • The Discount Rate was trimmed slightly to 6.60% from 6.65%, implying a marginally lower required return in the updated assumptions.
  • Revenue Growth is set at 8.78% compared with the prior 8.51%, indicating a small adjustment to expected top line expansion for AXA in euro terms.
  • The Net Profit Margin is now 7.77% versus 7.80% previously, a very small reduction in the assumed level of earnings retained from each € of revenue.
  • The Future P/E has been revised modestly higher to 11.40x from 11.23x, signaling a slightly higher valuation multiple applied to AXA's projected earnings.
8 viewsusers have viewed this narrative update

Key Takeaways

  • Digitalization, AI, and operational efficiencies are set to drive improved customer acquisition, cost savings, and revenue growth, especially among underserved and price-sensitive segments.
  • Expansion in health solutions, product innovation in Life & Savings, and growth into emerging markets will underpin sustained earnings growth and greater geographic diversification.
  • Currency weakness, softening insurance markets, limited European growth, execution risks in digital transformation, and climate-related claims all threaten future profitability and earnings stability.

Catalysts

About AXA
    Through its subsidiaries, insurance, asset management, and banking services worldwide.
What are the underlying business or industry changes driving this perspective?
  • Strong momentum in digitalization, AI adoption, and streamlined direct distribution (bolstered by the Prima acquisition) is expected to drive future cost efficiencies, improved customer acquisition, and expanded market share among digitally savvy, price-sensitive, and underserved customer segments, supporting higher future revenue growth and net margins.
  • Ongoing investment and innovation in Health (including care delivery, prevention, and integrated digital health solutions) positions AXA to capture increasing demand triggered by rising health awareness, regulatory focus, and global demographic shifts, which will underpin sustained top-line growth and expand net margins via better claims management and reduced fraud/waste.
  • The rejuvenation and positive net flows in Life & Savings-driven by product innovations and better persistency-are expected to convert into higher Contractual Service Margin (CSM) release and sustained earnings growth as the aging global population increases demand for retirement and protection products.
  • Expansion into emerging markets and strengthening of diversified distribution (e.g., partnerships with Correos in Spain and Lloyds Bank in the UK) is anticipated to open new customer bases where insurance penetration is lower, providing a long-term runway for revenue growth and geographic diversification of earnings.
  • Operational efficiency initiatives-including simplification, modernization of tech platforms, and disciplined cost management-are expected to further reduce the expense ratio and support higher underlying ROE and earnings, reinforcing AXA's ability to deliver attractive returns despite a complex macro and regulatory environment.
AXA Earnings and Revenue Growth

AXA Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming AXA's revenue will grow by 8.8% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 7.7% today to 7.8% in 3 years time.
  • Analysts expect earnings to reach €9.5 billion (and earnings per share of €4.89) by about July 2029, up from €7.3 billion today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 11.4x on those 2029 earnings, down from 12.6x today. This future PE is lower than the current PE for the GB Insurance industry at 11.8x.
  • Analysts expect the number of shares outstanding to decline by 3.65% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.6%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Persistently unfavorable foreign exchange (FX) movements, notably the weaker US dollar and currency volatility in key Asian markets, have already led to a reduction in net income and book value, and continued FX headwinds could further erode reported earnings and shareholder value over the long term.
  • The intensifying soft market conditions in reinsurance and select commercial lines (e.g., US property rates turning negative, slowing pricing momentum at AXA XL) may put pressure on underwriting margins, increasing the risk that earnings and combined ratio improvements fall short of current targets.
  • Overexposure to mature European markets, especially in core life and health insurance, creates structural limitations for revenue growth as these markets face stagnation and slow premium expansion compared to higher-growth emerging geographies.
  • Reliance on ambitious operational efficiency gains, particularly from investments in technology, digitalization, and AI, creates execution risk-as the projected margin improvements and cost reductions are not yet fully realized, and failure to deliver these could constrain future net margins and earnings growth.
  • Ongoing climate change and increased frequency of natural catastrophes pose a risk of higher claims volatility and potential underwriting losses, threatening future profitability and putting additional pressure on reinsurance costs and AXA's net results.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €48.51 for AXA based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €77.1, and the most bearish reporting a price target of just €40.32.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €121.9 billion, earnings will come to €9.5 billion, and it would be trading on a PE ratio of 11.4x, assuming you use a discount rate of 6.6%.
  • Given the current share price of €44.5, the analyst price target of €48.51 is 8.3% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on AXA?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

€48.51
vs €44.767.7% undervalued intrinsic discount
PastFuture0131b2015201820212024202620272029Revenue €121.9bEarnings €9.5b
8.8%
Revenue growth
7.8%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on AXA

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Good value with adequate balance sheet and pays a dividend.

Market cap€92.3b
PB2.0x
Estimated Growth7.3%
Dividend Yield5.2%
Full analysis

CEO & management

Thomas Buberl
CEO
6.2yrs
CEO Tenure

Through its subsidiaries, insurance, asset management, and banking services worldwide.